Sign up to save your podcasts
Or
Share Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
Combination regimens improve survival in advanced EGFR-mutated NSCLC, but they also increase toxicity. Jorge Nieva, MD, shares how he talks with patients about potential adverse events. He
describes the options available for prophylaxis and how he treats the toxicities that do arise.
View all episodes
By Oncololgy News CentralCombination regimens improve survival in advanced EGFR-mutated NSCLC, but they also increase toxicity. Jorge Nieva, MD, shares how he talks with patients about potential adverse events. He
describes the options available for prophylaxis and how he treats the toxicities that do arise.
More shows like Oncology News Central Peer-Spectives
View all
ASCO Daily News
59 Listeners
Digital Pathology Podcast
8 Listeners
Oncology On The Go
4 Listeners
Two Onc Docs
195 Listeners